Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet
January 26, 2023 08:00 ET
|
Nemaura Medical, Inc
Nemaura to integrate its proBEATTM glucose sensors with HealthFleet’s proven RestoreHealth wellness program targeted at U.S. market LOUGHBOROUGH, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical,...
Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
January 24, 2023 08:00 ET
|
Nemaura Medical, Inc
Average weight loss of 3.7 pounds and an average BMI reduction of 0.6 after 10 weeks in initial patients LOUGHBOROUGH, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:...
Nemaura Medical to Present at the Sidoti & Co. Micro Cap Virtual Conference
January 11, 2023 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic...
Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022
December 01, 2022 08:15 ET
|
Nemaura Medical, Inc
Loughborough, England, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic...
Nemaura Commences Pilot Program of Miboko with the NHS in the United Kingdom
November 29, 2022 08:00 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive...
Nemaura Medical Reports Fiscal Second Quarter 2023 Results and Provides Business Update
November 15, 2022 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical to Present at the MicroCap Rodeo Windy City Roundup 2022 Conference
October 04, 2022 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable...
Nemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura’s Diabetes Management Program in the U.S.
September 27, 2022 08:00 ET
|
Nemaura Medical, Inc
CHICAGO and LOUGHBOROUGH, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising...
Nemaura Medical to Present at the 24th Annual H.C. Wainwright Global Investment Conference
September 06, 2022 08:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable...
Nemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business Update
August 15, 2022 08:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...